Latest Regulation News

ASX Compliance has formally queried Reckon Limited regarding a late filing of a director interest notice, raising potential breaches of key listing rules. The company must respond swiftly to avoid trading disruptions.

The Takeovers Panel has received a formal review application challenging its recent decision on Humm Group Limited, signaling potential further scrutiny of the corporate governance dispute.

Atlantic Lithium secures a crucial green light from Ghana’s Parliament for its Ewoyaa Lithium Project, marking a key step towards production and investment decisions.

Merino & Co. Limited has attributed the late lodgement of director interest notices to an administrative oversight and reaffirmed its compliance measures to meet ASX disclosure rules.

Bass Oil has received regulatory approval to award the drilling contract for its Bunian 6 well in Indonesia, aiming to add 500 barrels of oil per day to current production by mid-year.

Horizon Oil has released a first supplementary and replacement bidder’s statement for its off-market takeover offer for Cue Energy, proposing a mix of cash and shares that values Cue at a 10-14% premium. The deal aims to create a diversified oil and gas producer across Asia-Pacific with significant synergies.

Lakes Blue Energy has temporarily halted gas flow testing at its Wombat-5 well to conduct extended pressure analysis, planning a perforation program to enhance production prospects.

Infotrust has agreed to acquire Canberra-based Catalyst Cyber, marking a strategic push into federal government cyber security markets with an expected earnings boost from the deal.

The Takeovers Panel has declared unacceptable circumstances in Humm Group's handling of Credit Corp's takeover proposal, citing misleading disclosures and insider share acquisitions that cloud market fairness.

CuFe Ltd has significantly upgraded the Orlando Copper-Gold Deposit resource classification at Tennant Creek, boosting Indicated tonnes to 87% and enabling underground mining studies. This milestone enhances the project’s economic outlook with critical minerals now factored into upcoming development plans.

Biotron Limited reveals that its lead antiviral candidate BIT-HBV001 shows promising activity against Hepatitis Delta Virus, expanding its potential impact beyond Hepatitis B. Meanwhile, the company completes integration of Sedarex and advances regulatory plans for its anaesthetic SedRx.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.2657 per security for its PERLS XII capital notes, payable mid-June 2026.